Top brand choice
Strength | Pack Size | Qty | |
---|---|---|---|
Strength
50mg
|
We guarantee the lowest price on all of our prescription products. If you find your medications cheaper at any other recognized licensed mail order pharmacy, we will not only match their price, we will beat it by 25% of the difference. It is our 125% price match guarantee!
Example: If you find a product on Canada Drugs Direct for $50.00 and find the same product for $40.00 at another mail order pharmacy, we will provide you with a $12.50 discount, bringing your total to $37.50.
To get the discount please make sure to mention the price match to the customer service team when they call to collect payment for your order. Or call toll free at 1-888-904-8467 to place the order through the phone.
Terms & Conditions of Program
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Your doctor may prescribe Tafinlar to treat advanced melanoma, a type of skin cancer. It is a kinase inhibitor that targets the BRAF protein, which is involved in the growth and spread of cancer cells.
Tafinlar is often used with another medication, Mekinist (trametinib), for treating melanoma that has spread to other parts of the body or cannot be surgically removed.
Fact Table | |
Formula |
C23H20F3N5O2S2 |
License |
US DailyMed, EU EMA |
Bioavailability |
95% |
Legal status |
Rx-Only |
Chemical Name |
Dabrafenib |
Elimination half-life |
8 hours |
Dosage (Strength) |
- |
Pregnancy |
Consult Doctor |
Brands |
Tafinlar |
Protein binding |
99.7% |
PubChem CID |
44462760 |
MedlinePlus |
a613038 |
ChEBI |
75045 |
ATC code |
L01EC02 |
DrugBank |
DB08912 |
KEGG |
D10064 |
Routes of administration |
By mouth |
The usual dosage is 150 mg orally twice daily with or without food. Do not crush, chew, or break the tablets.
The active ingredient in Tafinlar is dabrafenib.
The most common interactions occur between Tafinlar and:
Tafinlar may cause serious side effects, including skin cancer, new or worsening squamous cell carcinoma of the skin, or a type of inflammation called colitis. You should tell your doctor if you have a previous history of skin cancer or inflammatory bowel disease before starting treatment with Tafinlar.
Ask your healthcare team about a complete list of side effects that apply to you.
Tell your doctor or pharmacist if you experience any of the following: